Bellerophon Therapeutics Inc (BLPH)
0.0554
0.00 (0.00%)
USD |
OTCM |
Apr 26, 16:00
Bellerophon Therapeutics Cash from Operations (TTM): -12.34M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -12.34M |
June 30, 2023 | -11.02M |
March 31, 2023 | -9.768M |
December 31, 2022 | -17.77M |
September 30, 2022 | -17.40M |
June 30, 2022 | -17.97M |
March 31, 2022 | -19.67M |
December 31, 2021 | -22.82M |
September 30, 2021 | -25.25M |
June 30, 2021 | -24.58M |
March 31, 2021 | -23.43M |
December 31, 2020 | -19.88M |
September 30, 2020 | -16.37M |
June 30, 2020 | -15.42M |
March 31, 2020 | -14.93M |
December 31, 2019 | -12.94M |
September 30, 2019 | -14.10M |
June 30, 2019 | -15.52M |
Date | Value |
---|---|
March 31, 2019 | -17.39M |
December 31, 2018 | -15.50M |
September 30, 2018 | -15.93M |
June 30, 2018 | -13.79M |
March 31, 2018 | -12.68M |
December 31, 2017 | -15.90M |
September 30, 2017 | -13.82M |
June 30, 2017 | -13.91M |
March 31, 2017 | -14.18M |
December 31, 2016 | -17.21M |
September 30, 2016 | -32.09M |
June 30, 2016 | -39.71M |
March 31, 2016 | -44.17M |
December 31, 2015 | -46.26M |
September 30, 2015 | -41.36M |
June 30, 2015 | -45.19M |
March 31, 2015 | -48.76M |
December 31, 2014 | -70.56M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-25.25M
Minimum
Sep 2021
-9.768M
Maximum
Mar 2023
-17.29M
Average
-16.88M
Median
Cash from Operations (TTM) Benchmarks
Janux Therapeutics Inc | -50.58M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |